Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries.

In the models of the study, factors related to the structure of the healthcare system and the pharmaceutical system contributed most to pharmaceutical expenditure as a share of GDP. Moreover, disease profiles show its predictive role in the second model for Iran.